USCB Financial Holdings, Inc.
NASDAQ:USCBBanks - Regional
+$0.12 today
- Market cap
- $361.66M
- Beta
- 0.52
- P/E (TTM)
- 12.7
- EPS (TTM)
- $1.52
- Dividend yield
- 2.34%
Volume 0.14M
Average 0.05M
USCB Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
USCB Financial Holdings, Inc.NASDAQ: USCB
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 19.4% from a year ago
Cash & equivalents stood at $78.96M at the end of Q1 FY2026, down 19.4% from a year earlier and down 4.1% from the prior quarter. Over 3 fiscal years it compounded at +15.0% a year.
Context
- Cash & equivalents amounted to 2.8% of total assets at the end of Q1 FY2026, down 0.9 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -19.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 82.34M USD
- Year-over-year change
- +6.9%
- 4-year CAGR
- +15.5%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 82.34M | +6.9% |
| FY2024 | 2024-12-31 | 77.04M | +87.6% |
| FY2023 | 2023-12-31 | 41.06M | -24.2% |
| FY2022 | 2022-12-31 | 54.17M | +17.2% |
| FY2021 | 2021-12-31 | 46.23M | — |
Cash & Equivalents vs competitors
How USCB compares with its peers on the latest reported figures
- USCB's Mar 2026 cash & equivalents of $78.96M is the 10th highest of the 11 companies compared; the peer median is $159.4M.
- Its year-over-year change of -19.4% is the 9th highest of 11, against a peer median of +2.1%.
- Cash & equivalents amounts to 2.8% of total assets for USCB, versus a peer median of 4.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $257.54M | +56.9% | +33.4% | 9.5% | |
| Mar 2026 | $220.24M | +4.6% | +136.2% | 5.5% | |
| Mar 2026 | $208.9M | -28.5% | -13.3% | 6.2% | |
| Mar 2026 | $196.91M | -17.8% | -31.5% | 4.7% | |
| Mar 2026 | $174.1M | -0.3% | +4.1% | 5.0% | |
| Mar 2026 | $144.7M | +5.0% | -31.6% | 6.5% | |
| Mar 2026 | $140.68M | -10.5% | +36.1% | 4.4% | |
| Mar 2026 | $114.54M | +176.4% | +7.4% | 2.5% | |
| Mar 2026 | $113.02M | +11.6% | -6.0% | 1.7% | |
| Mar 2026 | $78.96M | -19.4% | +15.0% | 2.8% | |
| Mar 2026 | $9.37M | -96.3% | +82.3% | 0.3% | |
| Peer median (excluding USCB) | $159.4M | +2.1% | +5.7% | 4.8% | |
Competitors are the stored peer set for USCB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 46.23M | 54.17M | 41.06M | 77.04M | 82.34M |
| Short-term Investments | 0 | 0 | 229.33M | 217.2M | 0 |
| Net Receivables | 5.98M | 7.55M | 10.69M | 10.95M | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 52.2M | 61.71M | 281.08M | 305.18M | 82.34M |
| Property, Plant & Equipment (Net) | 19.46M | 19.66M | 16.26M | 13.01M | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 1.7B | 1.91B | 1.93B | 2.16B | 487.63M |
| Tax Assets | 34.93M | 42.36M | 37.28M | 29.65M | 0 |
| Other Non-current Assets | 48.12M | 53.41M | 69.76M | 76.88M | 2.13B |
| Total Non-current Assets | 1.8B | 2.02B | 2.06B | 2.28B | 2.62B |
| Total Assets | 1.85B | 2.09B | 2.34B | 2.58B | 2.8B |
| Account Payables | 9.48M | 13.73M | 15.56M | 20.37M | 2.45B |
| Short-term Debt | 0 | 0 | 5M | 16M | 51.46M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.59B | 1.83B | 1.94B | 2.17B | 0 |
| Total Current Liabilities | 1.6B | 1.84B | 1.96B | 2.21B | 2.5B |
| Long-term Debt | 36M | 46M | 178M | 147M | 39.29M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 50.19M | 60.4M | 189.42M | 155.45M | 39.29M |
| Total Liabilities | 1.65B | 1.9B | 2.15B | 2.37B | 2.59B |
| Common Stock | 19.99M | 20M | 19.58M | 19.93M | 20.08M |
| Retained Earnings | (124.25M) | (104.1M) | (88.55M) | (67.81M) | (67.81M) |
| Accumulated OCI | (2.52M) | (44.75M) | (44.27M) | (44.53M) | (17.76M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 203.9M | 182.43M | 191.97M | 215.39M | 212.39M |
| Total Debt | 50.19M | 60.4M | 194.42M | 171.45M | 90.75M |
| Net Debt | 3.96M | 6.23M | 153.36M | 94.42M | 8.41M |
USCB Financial Holdings, Inc.
NASDAQ:USCB
Intrinsic Alpha fair value
Locked
Current Price
$19.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.